Answers are grounded in this paper and cite their sources.
IAPs (inhibitors of apoptosis proteins) might have a major role in the apoptotic resistance that marks many cancers. The studies on IAPs in human HCC have focused on survivin or XIAP, indicating that their new or increased expression in this tumor is associated with a more unfavorable prognosis. The present results corroborate these findings, emphasizing the role that the coordinated expression of different IAPs and alternative splice variants might play in the adverse biology of hepatocellular carcinoma.
No takes yet. Share an insight, caveat, or question.
Notarbartolo et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: